Corporate News
Block Listing Six Monthly Review
22 March 2023
Omega Diagnostics Group Plc (the “Company”) provides below the information required by Schedule Six of the AIM Rules for Companies in connection with the unexercised warrants issued pursuant to the Company’s capital fundraise announced 6 May 2022 (“Warrants”).
Date: 22 March 2023
| Name of applicant: | Omega Diagnostics Group PLC | |||
| Name of scheme: | Unexercised Warrants, pursuant to the Company's capital fundraise announced 6 May 2022. | |||
| Period of return: | From: | 11 May 2022 | To: | 22 March 2023 |
| Balance of unallotted securities under scheme(s) from previous return: | Nil ordinary shares of 4p each (“Ordinary Shares”) | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Warrants: 90,000,000 Ordinary Shares | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | Warrants: nil | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | Warrants: 90,000,000 Ordinary Shares | |||
| Name of contact: | Chris Lea, Company Secretary |
| Telephone number of contact: | 020 7933 8780 |
